Form 4 Tracker
John F Sheridan

Director, PRESIDENT & CEO · 4 filings · Latest: Aug 15, 2026

TANDEM DIABETES CARE INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TNDM
John F SheridanDirector, PRESIDENT & CEOAug 15, 2026
Option Exercise
$0.0015,916—165,315
TNDM
John F SheridanDirector, PRESIDENT & CEOMay 15, 2026
Option Exercise
$0.0051,189—170,051
TNDM
John F SheridanDirector, PRESIDENT & CEOFeb 17, 2026
Option Exercise
$0.0011,454—127,091